Natural killer (NK) cells express killer inhibitory receptors that mediate negative regulation of NK cell cytotoxicity upon binding to MHC class I molecules on target cells. Unrelated inhibitory receptors on B cells have recently been shown to function through recruitment of phosphotyrosine phosphatase 1C . Here, we show that a human killer inhibitory receptor specific for HLA-C also recruits PTP-1C after phosphorylation induced either by the pharmacological agent phenylarsine oxide or by conjugation with target cells. This recruitment is mediated by the binding of specific cytoplasmic phosphotyrosine-containing sequences to PTP-1C. These results implicate PTP-1C as a cytosolic component of the negative signaling pathway through NK cell inhibitory receptors.
C
Ytotoxicity by NK cells is controlled by an interplay of signals from both stimulatory and inhibitory cell surface receptors (1) . Activating receptors trigger NK cellmediated cytotoxicity upon binding to specific target cell ligands. Killer inhibitory receptors (KIRs) 1 engage with MHC class I molecules on target cells, blocking the functional capacity of the stimulatory receptors. When target cells lose or reduce expression of MHC class I molecules as a consequence of transformation or viral infections, the balance between activation and inhibition is altered, resulting in the release of target-directed NK cell cytotoxicity.
Human KIRs have recently been identified by mAbs and cDNA cloning as transmembrane glycoproteins of the Ig superfamily that recognize the distinct polymorphic determinants of HLA-B and -C molecules (2) (3) (4) (5) (6) (7) . Structurally, the extracellular region of these receptors is composed of two (HLA-C receptors) or three (HLA-B receptors) Ig superfamily domains. The cytoplasmic region includes a motif characterized by two tyrosine-x-x-leucine (YXXL) pairs spaced by 26 amino acids. A subgroup of KIRs lack this motif because of a premature truncation of the cytoplasmic tail and function as activatory rather than inhibitory receptors (8) .
Recent observations in B cells have suggested a potential role for these cytoplasmic tyrosines in the function of KIRs. The B cell-surface receptors Fc~/RIIB1 and CD22 are characterized by cytoplasmic tyrosine-containing sequences, termed immune receptor tyrosine-based inhibitory motifs (ITIM) (9) (10) (11) (12) , which bind the SH2 domain(s) of protein tyrosine phosphatase-lC (PTP-1C, also known as SHPTP-1, SHP, or HCP; 13-16) upon phosphorylation (9, 17) . Coligation of FcgRIIB1 with the B cell antigen receptor (BCR) induces ITIM tyrosine phosphorylation, recruitment of PTP-1C, and subsequently inhibits the capacity of the BCR to activate phospholipase C and to mobilize calcium (9) . Similarly, CD22, which is weakly associated with BCR, becomes tyrosine phosphorylated and recruits PTP-1C upon BCR cross-linking (17) . Separating CD22 from BCR with anti-CD22 antibody can substantially enhance proliferative responses induced by BCR cross-linking (17) . The ITIM motit~ in CD22 and Fc~/RIIB1 are surprisingly similar to the YXXL motifs of the human KIRs. A further parallel with CD22 and Fc',/RIIB1 is the observation that ligation of inhibitory receptors by MHC class I molecules on target cells inhibits the calcium mobilization in NK cells induced by susceptible target cells (18) .
These structural and functional parallels between the human KIRs and the CD22 and Fc',/RIIB1 receptors have suggested a role for a phosphatase in KIR function (5, 19) . Therefore, we investigated whether the KIRs also bind PTP-1C upon tyrosine phosphorylation. The results indicate that a human p58 KIR specific for HLA-C indeed binds PTP-1C upon phosphorylation of either tyrosine residue.
721.221 is a class I-deficient, human EBV-transformed lymphoblastoid cell line (21) , and the HLA-C transfectants of 721.221 have been described (22) . Cell-surface expression of class I alleles was periodically tested by FACS | analysis (Becton Dickinson & Co., Mountain View, CA) using the W6/32 mAb (mouse tgG2a anti-HLA-A, -B, and -C; American Type Culture Collection, P`ockville, MD) and the F4/326 mAb (mouse IgG1 anti-HLA-C; kindly provided by Soo Young Yang, Sloan-Kettering Institute, New York, NY; 23). Anti-p58 KIP. monoclonal antibody HP-3E4 (mouse IgM) has been previously described (4) . The anti-mouse IgM mAb b-7-6 (rat IgG1, kindly provided by Dr. John Cambier, National Jewish Center, Denver, CO) was conjugated to cyanogen bromide-activated Sepharose 4B beads (Phannacia Biotech Inc., Piscataway, NJ) according to the manufacturer's instructions. Anti-PTP-1C antibody (rabbit polyclonal) and horseradish peroxidase (HR.P)-conjugated antiphosphotyrosine mAb (4G10; mouse IgG2b) were purchased from Upstate Biotechnology Inc. (Lake Placid, NY). Monoclonal anti-PTP-1C (mouse IgG1) was from Transduction Laboratories (Lexington, KY) and was detected with rabbit anti-mouse IgG-HP`P from Dako Corp. (Carpinteria, CA). The antiphosphotyrosine antibody PY20 (Transduction Laboratories) was conjugated to cyanogen bromide--activated Sepharose 4B beads (Pharmacia).
Peptides. The tyrosine-phosphorylated (p) and unphosphorylated p58 peptide sequences were EVTYAQLNH (YAQL), EVT (p)YAQLNH (pYAQL), IVYTELPNAE (YTEL), and IV(p) YTELPNAE (pYTEL). The control phosphopeptide sequence was (p)YMAPYDNY (amino acids 739-746 from the PDGF receptor [3; 24) . Peptides were synthesized with a carboxy-terminal amide by Quality Controlled Biochemicals, Inc. (Hopkinton, MA) and purified by reversed-phase (ri0) HPLC. Their purity was >97%, as assessed by rpHPLC, mass spectrometry, and 31p-NMP`. Peptides were coupled to AminoLink Plus coupling gel (1 mg/1 ml packed gel; Pierce Chemical Co., I<ockford, IL) overnight at 4~ and pH 7.2, according to the manufacturer's instructions. Coupling efficiency from the supernatant was determined by monitoring rpHPLC column elution at OD220. Peptide beads (~15 ~g/precipitation) were used immediately after coupling.
Cell-su~ace ~2Sl-Labeli~g. Cells were first labeled with a watersoluble Bolton-Hunter reagent (36 Izg/ml Sulfo-SHPP; Pierce) according to the method of Portol& et al. (25) and subsequently with Na125I (0.5 mCi/50 million cells; Amersham, Arlington Heights, IL) using Iodogen (Pierce), according to the manufacturer's instructions. 
Cytosolic Calcium Measurement of NK Cells

Metabolic Labeling with [3sS]Cysteine/Methionine.
Cells were washed twice with PBS and resuspended at 4 million/nil in cysteine/methionine-free DME (Sigma) containing 10% FCS (TBSdialyzed) and 1,000 U/ml rlL-2.
[3SS]methionine/cysteine (Amersham) was added at 0.1 bLCi/ml, and ceils were sealed in a 75-cm 2 culture flask and incubated at 37~ for 4 h. Cells were washed twice before subsequent lysis.
Cell Stimulations. For phenylarsine oxide (PAO) treatment, 30 million NK cells/ml were unstimulated (-) or stimulated (+) for 2 min with 100 ~M PAO (1 pA of 100 mM stock in DMSO) in a 37~ shaking heat block. An aliquot of 1 million cells was lysed in 4• reducing Laemmli sample buffer (27) and immediately frozen in liquid nitrogen, while the remainder was rapidly centrifuged, lysed in 1% Triton )(-100 buffer, and subjected to immunoprecipitation (see below). This PAO treatment regimen has been shown to produce optimal global tyrosine phosphorylation in T and B cells (28) (29) (30) . In conjugation experiments, 50 million NK cell clones (5F12) and/or 25 million target cells were mixed in 2 ml of IMDM medium at 37~ in a 14-ml round-bottom tube and immediately centrifuged at 2200 rpm for 5 s. Pelleted cells were incubated at 37~ for 2 rain, mixed with 10 ml icecold PBS containing 200 IzM sodium orthovanadate, pelleted for 2 min at 1,600 rpm, lysed in 1% Triton X-100 buffer, and subjected to immunoprecipitation (see below).
Protein Precipitations with Antibodies and Peptides. Cells were
lysed on ice in 1% Triton X-100 (Surfact-Amps; Pierce), 10 mM Tris, pH 7.4, 150 mM NaC1, 2 n~M Na orthovanadate, 1 mM Pefabloc SC (Boehringer-Mannheim), 0.4 mM EDTA, 10 mM NaF, and 1 p~g/ml each ofleupeptin, aprotinin, and soybean trypsin inhibitor (all from Sigma). Lysates were cleared by centrifugation at 12,000 rpm and precipitated with antibodies or gel-coupled peptides at 4~ for 2-4 h. HP-3E4 (I-3 pA of ascites/sample) was immunoprecipitated with b-7-6-coupled Sepharose, and W6/32 (100 I*1 culture supernatant/sample) was precipitated with protein A-Sepharose (Pharmacia). All precipitates were washed five to six times with lysis buffer and resuspended in reducing Laemmli sample buffer (27) .
Immunoblotting. Precipitated samples were boiled for 5 rain and separated on discontinuous SDS-PAGE according to the method of Laemmli (27) . Proteins were electrophoretically transferred to nitrocellulose (Hybond-C Extra; Amersham) and blocked with 5% BSA. Membranes were probed with either Hp`P-coupled 4G10 (375 ng/ml) or initially with anti-PTP-1C and secondarily with HI<P-coupled protein G or rabbit antimouse IgG-HP`P. Immunoblotted proteins were visualized by chemiluminescence using the ECL detection reagents (Amersham). Membranes were stripped of antibody by incubating for 30 lrfin at 50~ in 100 mM 2-ME, 2% SDS, 62.5 mM Tris, pH 6.7 according to a protocol supplied by Amersham. Stripped blots were reprobed after blocking. 3SS-labeled samples were subsequently autoradiographed from dried membranes.
PTP-1C Phosphatase Assay.
The src family tyrosine kinasederived phosphorylation site peptide P,I<LIEDAEYAAP`G (Santa Cruz Biotechnology) was 32p-phosphorylated by incubating for 3 h with fyn kinase inmmnoprecipitates in the presence of [32p]ATP, and was purified on P81 paper (Whatman, Clifton, NJ), eluted with 100 mM NH4HCO3, and lyophilized as described by Matthews et al. (16) . PTP-IC phosphatase was purified from lysates of the human NK cell clone, NK3.3, with pYAQL tyrosine phosphopeptide-coupled heads, eluted with 50 mM p-nitrophenyl phosphate, and washed and concentrated in a Centricon-30 (Amicon, Inc., Beverly, MA). Dephosphorylation of the 32p-peptide substrate by purified PTP-1C was assayed in the presence of p58-derived phosphopeptides for 30 min at 30~ (within the linear range ofpeptide dephosphorylafion), as described by Stmeh et al. (31) . About 50 ng of 32p-peptide labeled with ".,55,000 cpm was added to each 50-1xl sample of assay mixture.
Results
Inhibition of Cytotoxicity of NK Cell Clones by Class I Ligands is Paralleled by Inhibition of Calcium Mobilization.
The human NK cell clone 5F12 expresses the p58 KIR recognized by the HP-3E4 mAb, which has previously been shown to mediate NK cell inhibition by a group of HLA-C molecules on target cells that share Asn77-Lys s~ (2) . Indeed, in cytotoxicity assays, lysis of class I--deficient B cell line 721.221 by 5F12 was inhibited by transfection of HLA-Cw4, -Cw5, and -Cw6, whereas other HLA-C alleles did not affect cytotoxicity (data not shown).
To assess whether the inhibition of NK cell cytotoxicity was paralleled by changes in calcium mobilization in this clone, 5F12 was loaded with a calcium-reactive dye, indo-1, and conjugated with sensitive or resistant target cells. Cytosohc calcium levels were measured in the NK cells that formed conjugates. Interaction with sensitive target cells substantially elevated the mean cytosohc calcium levels in the conjugated NK cell population (Fig. 1) . Conjugation with HLA-C-transfected resistant target cells, however, resulted in only a minimal increase of cytosohc calcium in the NK cells during the same time course. Interestingly, masking of HLA-C in these resistant target cells with antibodies resulted in increased calcium mobilization in the NK cells (Fig. 1) , while the isotype-matched, anti-CD19 antibody had no effect in control experiments (data not shown). Therefore, the NK cell calcium mobilization response is negatively regulated by the interaction of inhibitory receptor with HLA-C molecules expressed on resistant target cells.
PTP-1C Associates with Tyrosine-phosphorylated p58 KIR.
Since in B cells, CD22 and Fc~/P,.IIB1 inhibitory receptors downregulate calcium mobilization by phosphorylation of ITIMs and binding with PTP-1C, we tested whether p58 KIR could be tyrosine phosphorylated in NK cells, and whether the phosphorylated KIR could bind PTP-1C. In initial experiments, we induced tyrosine phosphorylation in human NK cells by a pharmacologic agent, PAO, a potent phosphotyrosine phosphatase inhibitor that has been shown to induce substantial protein tyrosine phosphorylation in treated T and B lymphocytes (28) (29) (30) . Aliquots of the NK cell clone 5F12 were either untreated or treated with 100 IxM PAO for 2 min, then lysed and immunoprecipitated with anti-p58 or anti-HLA class I antibodies. Wholecell lysates and immunoprecipitates were separated by SDS-PAGE and analyzed by sequential immunoblotting using antiphosphotyrosine and and-PTP-1C antibodies 9 Antiphosphotyrosine immunoblotting revealed substantial increases in tyrosine phosphorylation of many proteins in whole-cell lysates ofPAO-treated NK cells, as compared to the untreated cells (Fig. 2 A, left panels) . PAO treatment also dramatically increased the intensity and number of tyrosine phosphorylated species in p58 immunoprecipitations. The major tyrosine phosphoprotein in this immunoprecipitation directly overlapped with the p58 protein (Fig.  2 B) , indicating that the p58 KII:( is inducibly tyrosine phosphorylated by PAO treatment. Additional p58-associated tyrosine phosphoprotein bands were detected with apparent molecular masses of 63, 71, 74, 78, and 105 kD. In control MHC class I immunoprecipitations, a single tyrosine phosphoprotein of "~ kD that was unaffected by PAO stimulation was detected.
Anti-PTP-1C immunoblotting detected equal amounts of a protein with the expected molecular mass of 65 kD in lysates from both untreated and PAO-treated cells (Fig. 2 A, Immunoprecipitates were separated on SDS-PAGE, the gel was dried, and labeled proteins were detected by autoradiography.
right panels). Interestingly, in the p58 l m m u n o p r e c i p i t a t e f r o m P A O -t r e a t e d cells, a substantial a m o u n t o f P T P -1 C was detected in association w i t h the p58 K I R , w h i l e only m i n i m a l a n t i -P T P -1 C reactivity was o b s e r v e d in i m m u n oprecipitates f r o m u n t r e a t e d cells. P T P -1 C was n o t detected in a n t i -M H C class I i r m n u n o p r e c i p i t a t e s f r o m either u ntreated or P A O -t r e a t e d cells. In conclusion, these results indicate that P A O induces substantial tyrosine p h o s p h o r y - lation o f p58 and association of P T P -1 C with p58 KIR. Moreover, P A O induces the phosphorylation of and/or association o f several additional tyrosine phosphoproteins that coprecipitate with the p58 KIR.
PTP-IC Is Recruited to p58 KIR upon N K Cell Conjugation with Target Cells.
Since P A O treatment is a nonphysiological stimulus of tyrosine phosphorylation, we also tested whether P T P -1 C could inducibly associate with p58 K I R upon receptor ligation that occurs during the conjugation of our characterized N K cell clone 5F12 with target cells. As shown in Fig. 3 , significant tyrosine phosphorylation is induced upon conjugation of the N K cells with either sensitive or resistant target cells, as has been shown previously by Kaufman et al. (18) . Immunoprecipitation o f p58 K I R from lysates of both cell conjugates revealed that a protein migrating at 58 kD was tyrosine phosphorylated and that numerous additional tyrosine phosphorylated proteins became associated with the receptor. Immunoblotting with anti-PTP-1C demonstrated that the phosphatase indeed becomes associated with p58 K I R upon conjugation o f N K cells with resistant targets. To a lesser extent, P T P -1 C also associated with p58 K I R upon conjugation with sensitive target cells, which was also observed in several additional experiments. Nevertheless, P T P -1 C associated more eflqciendy with p58 K I R upon N K cell interaction with resistant target cells. binding was examined with synthetic tyrosine phosphopeptides. Peptides containing sequences surrounding the p58 KItL tyrosine residues were coupled to AminoLink Plus coupling gel and used as affinity matrices to bind proteins from Triton X-100 lysates of 35S-metabolical]y labeled NK cell clone 5F12. Few, if any, proteins bound to unphosphorylated tyrosine-containing peptides, but phosphorylated versions of the same peptides bound several distinct protein species (Fig. 4 A, left panel) . The pYAQLcontaining phosphopeptide bound at least nine proteins of 54, 65, 69, 81, 83, 102, i08, 120, and 131 kD while the pYTEL-containing phosphopeptide bound a subset of the same proteins of 65, 69, 81, 108, 120, and 131 kD. Alternatively, a control tyrosine phosphopeptide from the cytoplasmic domain of the PDGF receptor-J3 exhibited different binding specificity and adsorbed three major proteins (60, 81, and 90 kD). The 65-kD protein band that was bound by both of the p58 phosphopeptides corresponded to the predicted molecular mass for PTP-1C. Subsequent immunoblotting identified this band as PTP-1C (Fig. 4 A, right panel). Nevertheless, PTP-1C routinely bound more to the pYAQL peptide than to the pYTEL peptide and was less susceptible to elution by 50 mM p-nitrophenylphosphate when associated with the pYAQL peptide (data not shown). Thus, both tyrosine residues in the cytoplasmic domain of p58 have the capacity to bind PTP-1C and additional proteins exhibit distinct binding capacities towards the phosphopeptides.
Both Tyrosine Residues in the Cytoplasmic
Both of the p58-derived tyrosine phosphopeptides elevated enzymatic activity of PTP-1C in a concentrationdependent manner, as presented in Fig. 4 B. The pYAQL phosphopeptide was more potent in enhancing phosphatase activity than pYTEL, which parallels the PTP-1C-binding capacity of the phosphopeptides. The combination of both phosphopeptides was at best additive. Unphosphorylated peptides or the PDGF receptor-derived tyrosine phosphopeptide did not stimulate phosphatase activity.
Discussion
These observations provide advances in our understanding of the mechanism of inhibitory receptor function in human NK cells. It has been previously shown that inhibition of the inositol phosphate turnover and calcium mobilization response are critical components of the downregulation of NK cell cytotoxicity by class I molecules (18) . Our results parallel these observations and imply a role for PTP-1C as a cytosolic mediator of KilL function. Upon tyrosine phosphorylation, the p58 KIlL binds to PTP-1C via two separate ITIM motifs, which may interact with one or both of the SH2 domains of PTP-1C. Recruitment of PTP-1C is paralleled by activation, as suggested by the stimulation of tyrosine phosphatase activity of PTP-1C in vitro (Fig. 4 B) by p58-derived phosphotyrosine peptides.
Tyrosine phosphorylation of p58 KIR and association of PTP-1C occurs in response to pharmacological stimulation with PAO, as well as to physiological conjugation of NK ceils with resistant target cells. In our experiments, p58 KIP, is also tyrosine phosphorylated when NK cells are conjugated with sensitive target cells. This is probably caused by a profound global tyrosine phosphorylation that is stimulated in NK cells that interact with sensitive target cells (18) . Still, PTP-1C is more efficiently recruited when the receptor is specifically engaged by the inhibitory ligand. It is also likely that PTP-1C is only one of the components of the inhibitory cascade. Further characterization of the additional proteins that bind p58 KIR (Fig. 3) and KIR phosphopeptides (Fig. 4 A) is underway.
The apparent role for PTP-1C in the inhibitory receptor mechanism is strikingly similar to the mechanism by which the Fc',/RIIB1 and CD22 receptors negatively regulate BCR function (9, 17) . A critical aspect of the mechanism of these inhibitory receptors is their direct association with the BCR, thereby bringing the phosphatase directly to the antigen receptor and negatively regulating calcium mobilization through the antigen receptor. FcylLIIB1 can be recruited to the BCR by bound antigens with associated serum IgG (9, 11, 12) , whereas CD22 is believed to be weakly associated with the BClL (17, 32) . It is not known whether KIRs are associated with an activating receptor(s) and whether this association is required to induce negative signaling. Previous experiments with bystander ceils have shown that NK cell cytotoxicity against class I-deficient target cells is not affected by the presence of class I-positive bystanding cells (22) . This lack of bystander effect suggests that the KilLs generate a negative signaling directed at the interface of effector-target cell interaction rather than a global cell anergy. Thus, colocalization of KIRs with stimulatory receptors may be required to mediate cross-talk inhibition. Further studies are required to characterize the human NK cell stimulatory receptors, determine whether they associate with inhibitory receptors, and establish how they are regulated through PTP-1C recruitment.
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